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Abstract The prediction of blood–brain barrier perme-
ation is vitally important for the optimization of drugs tar-
getingthecentralnervoussystemaswellasforavoidingside
effects ofperipheral drugs.Followingapreviouslyproposed
model on blood–brain barrier penetration, we calculated the
cross-sectional area perpendicular to the amphiphilic axis.
We obtained a high correlation between calculated and
experimental cross-sectional area (r = 0.898, n = 32).
Based on these results, we examined a correlation of the
calculated cross-sectional area with blood–brain barrier
penetration given by logBB values. We combined various
literature data sets to form a large-scale logBB dataset with
362 experimental logBB values. Quantitative models were
calculated using bootstrap validated multiple linear regres-
sion. Qualitative models were built by a bootstrapped ran-
dom forest algorithm. Both methods found similar
descriptors such as polar surface area, pKa, logP, charges
and number of positive ionisable groups to be predictive for
logBB. In contrast to our initial assumption, we were not
abletoobtainmodelswiththe cross-sectional areachosenas
relevant parameter for both approaches. Comparing those
two different techniques, qualitative random forest models
are better suited for blood-brain barrier permeability
prediction, especially when reducing the number of
descriptors and using a large dataset. A random forest pre-
diction system (ntrees = 5) based on only four descriptors
yields a validated accuracy of 88%.
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Abbreviations
BBB Blood-brain barrier
CNS Central nervous system
CSA Cross-sectional area
LogBB Logarithmic ratio between concentration of a
compound in brain and blood
P-Gp P-glycoprotein transporter
TPSA Topological polar surface area
Introduction
The blood–brain barrier (BBB) is a complex system, tightly
regulating the transport from and to the central nervous
system (CNS) [1]. It separates the systemic bloodstream
from the CNS and is therefore important for drug diffusion
and transport between them [2]. Drugs targeting the CNS
need to be able to pass the BBB to reach their target [3]. In
contrast, low BBB permeability reduces the chance of
undesirable CNS-related side effects [4, 5]. Therefore an
early estimation of BBB permeability would be highly
valuable for drug design [6, 7]. The relevance of BBB
permeability of therapeutic drugs has been reported in the
context of numerous clinical dysfunctions, like dementia
[8] and other clinical disorders [9–11].
The most common numeric value describing perme-
ability across BBB is the logBB [12]. It is deﬁned as
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logBB ¼ log
cBrain
cBlood

ð1Þ
Unfortunately, experiments to measure logBB are time-
consuming, laborious and expensive in vitro [13–16] and
even more in vivo [17, 18]. So it is not surprising that the
number of published experimental values is limited.
Experimental methods to assess BBB permeability range
from artiﬁcial membranes and complex cell culture systems
to in vivo methods. The PAMPA assay uses artiﬁcial
membranes to observe passive (effective) membrane
permeability, quantiﬁed by Peff [19, 20]. Obviously, those
experiments are only able to observe permeability,
neglecting the special characteristics of the BBB.
Nevertheless, results from these studies support the
validity of lipid bilayer systems as strongly simpliﬁed
representations of the BBB. The main drawback of cell-free
methods is that they neglect active transporters acting at the
BBB and therefore incorrectly predict substrates to
transport systems [21]. Numerous active transport systems
and efﬂux transport systems play an important role at the
BBB [22, 23]. One of the mostcommonly reported transport
systems acting at the BBB is P-Glycoprotein (P-Gp) [24–
26]. In contrast, in vivo methods, like in situ brain perfusion
[17], are able to capture real BBB permeability as given by
PS (permeability surface product) or logPS values [27].
Due to these experimental difﬁculties, it is not surpris-
ing, that BBB is frequently addressed via computational
approaches. Computer-aided methods applied to this ﬁeld
of interest include multiple linear regression [28–32],
bagged regression [33], partial least square analysis [34–
37], support vector machines [38–40] and artiﬁcial neural
networks [39, 41]. These methods are frequently combined
with descriptor selection algorithms based on genetic
algorithms to name only one [42, 43]. A comprehensive
overview of previous models for BBB prediction has been
published by Vastag and Keseru [44].
Depending on the size of the dataset, the number of
descriptors, and the mathematical approach for prediction
range from rough guidelines to quantitative predictions.
Complex methods like partial least square analysis and arti-
ﬁcialneuralnetworkssufferfromthedrawbackofbeinghard
to interpret, whereas simple methods like multiple linear
regressionoftenyieldlessaccurateresultsorevenonlyrough
guidelines[45].Althoughdifferentmathematical techniques
makeithardtocomparetheresultsdirectly,theperformance
decreases strongly with larger datasets. High squared corre-
lation coefﬁcients above 0.85 are reported frequently for
focused data sets with a size of approximately 50–90 com-
pounds [31]. Predictions based on larger compound collec-
tions with a size of over 200 compounds resulted mainly in
‘‘rules of thumb’’ for good BBB permeability [45]. Alto-
gether, these ﬁndings clearly show that there is still need for
further research on BBB permeability [46].
Summarizing recent work, there is broad agreement on
the importance of some molecular properties and descrip-
tors which have been found in numerous publications to
inﬂuence BBB permeability [45]:
• The descriptor most frequently reported with BBB
permeability is the polar surface area. The majority of
publications report correlation of logBB with the polar
surface [30, 47] or a property closely related to it [35].
The sum of oxygen and nitrogen atoms for example is
extremely cheap in computation-time, but has still
proven to be useful.
• There is consensus that BBB permeability is also highly
inﬂuenced by lipophilicity [48, 49]. One way to quantify
lipophilicity is logP, the logarithmic partition coefﬁcient
between 1-octanol and water. However, the ability of
logP to represent lipophilicity come under discussion
recently [50], as octanol is a good hydrogen donor and
thereforeprobablynotatypicalapolarsolvent,evenmore
when used as a calculated in silico descriptor [50, 51]. In
additiontothat,logPisdeﬁnedfortheneutralizedstateof
a compound. LogP values for ionized (e.g. protonated)
compounds are basically not deﬁned [52]. Liu et al. [47]
introduced ‘lipoafﬁnity’ as an easily-accessible descrip-
tor. It is calculated by adding the contributions to the
logP values of all but nitrogen and oxygen atoms.
• Molecular ﬂexibility has also been reported to inﬂuence
BBB permeability. This is in agreement with the theory
we used in this study (see below), since rigid molecules
seem to ﬁt less well to the membrane than more ﬂexible
ones (given that both molecules have approximately the
same weight) [53]. A simple descriptor representing
molecular ﬂexibility would be the number of rotatable
bonds, for example [29].
In this study we followed an approach based on physico-
chemical properties to address permeation across the BBB,
proposed by Fischer et al. [53]. According to this hypoth-
esis, the process of integrating a compound into a mem-
brane can be split into essential steps that can be added up
to form the process of membrane permeation:
• Intheﬁrststepthecompoundneedstobedesolvatedfrom
the aqueous environment. The process of desolvation is
oftenaddressedbymoleculardynamicssimulations[54].
Simultaneously, a cavity, appropriate for embedding the
compound within the membrane is created. The amount
ofenergyrequiredtocreatethiscavityiscorrelatedtothe
energy needed to insert a molecule into the membrane.
Fischer et al. [53] assume that the size of this cavity is
crucial for membrane permeation.
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cavity. It is stabilized by electrostatic interactions with
the polar headgroup of lipids and hydrophobic interac-
tions with the core region of the lipid bilayer [55].
• Finally, the compound needs to resolvate behind the
lipid bilayer. This process is similar to the reversion of
the solvation process.
Figure 1 schematically illustrates how a molecule is
inserted into a membrane according to this hypothesis.
Based on this theory Gerebtzoff and Seelig [56] introduced
the cross-sectional area (CSA) of a molecule as a novel
descriptor to presumably represent BBB permeability.
Because of its well-founded physico-chemical background
it promised to achieve good predictability and interpret-
ability, although this descriptor neglects all thermodynamic
aspects of desolvation and resolvation. Descriptors based
on valid mechanistic models have proven to contribute to
the design and optimization of drug molecules [57]. Thus
we reproduced this promising molecular descriptor and
critically analysed its ability to predict BBB permeability.
For this purpose, we compiled a large data set with
experimental logBB values from numerous published
datasets, instead of using single focused sets.
Methods
Calculation of the CSA
We calculated the amphiphilic axis and CSA, as described
in detail in Gerebtzoff and Seelig [56]. Modiﬁcations were
introduced wherever the description was not clear or the
results did not match our expectations. The following
section describes and explains these modiﬁcations.
The amphiphilic axis is deﬁned by the hydrophobic and
hydrophilic center of a molecule. The hydrophilic center
was calculated by averaging oxygen and nitrogen atom
positions weighted by their contribution to the topological
polar surface area (TPSA). Assuming that hydrogen bonds
mainly inﬂuence BBB permeability [32], we decided to
consider only nitrogen and oxygen as hydrophilic atoms
and neglect sulphur atoms. The weighting factors were
based on TPSA provided by MOE [58]. To emphasize the
increased polar character of charged atoms compared to
polarized atoms, we assigned a factor of 100 to charged
atoms according to Eq. 2, where wf is the weighting factor,
z is the charge and w0 is the weighting factor according to
the TPSA.
wf ¼ 100   z þ w0   1   z ðÞ ð 2Þ
Halogen and carbon atoms were taken into account to
place the hydrophobic center. Hydrophobic atom positions
were weighted by their contribution to logP prediction by
MOE (logP(o/w)) [59]. This fragment-based calculated
logP suggests that halogen atoms have a large negative
contribution to logP, which results in a displaced
hydrophobic center for molecules containing halogen
atoms. Thus we removed the logarithm before weighting
to avoid negative contributions. Removal of the logarithm
resulted in a more intuitive placement of the hydrophobic
center (see Fig. 2.)
According to the mechanism outlined by Fischer et al.
[53], a molecule inserts into a membrane along the amphi-
philic axis. The CSA reﬂects the area occupied by the mol-
ecule when projected to the plane perpendicular to the
amphiphilic axis (see Figs. 1, 3). Projecting a molecule onto
anareareducescomputationaleffortsfrom3Dinto2Dspace,
whichdramaticallyincreasesthecalculationspeedforlarger
molecules in contrast to the published procedure [56].
Calculation of amphiphilic axis and CSA were per-
formed with MOE [60] using its scripting language SVL
(complete script is available as supplementary informa-
tion). Partial charges were calculated using MMFF94x
forceﬁeld. Protonation states were assigned according to
physiological pH of 7.4.
Experimental CSA values
To validate our CSA calculations, we compared our results
with experimental CSA values [56]. We obtained all
structures as SDF ﬁles from PubChem [61]. The reported
dataset [56] consists of 32 compounds with experimental
CSA values for pH 7.4 and 8. The experimental CSA at pH
7.4 was used, as it represents physiological pH. Carebastine
Fig. 1 The cross-sectional area (CSA) has been introduced as a
measure for the area occupied by a compound after insertion into a
lipid membrane. Local polarity of the membrane determines the
orientation of the ligand
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8 and 7.4 differed signiﬁcantly. We also removed beta-
cyclodextrin from the dataset, since it is not a typical drug-
like molecule with a molecular weight over 1,000 Da (see
Lipinski’s rule-of-5 [62]). For each compounds the most
stable conformation according to its conformational energy
calculated by Omega (version 2.0) was used to calculate
the CSA.
Experimental logBB values
Incontrasttothe small numberofexperimental CSA values,
various studies containing experimental logBB values have
been published. To investigate the ability of CSA for logBB
prediction we combined all available published datasets and
generatedanovellargelogBBdataset.Ourdatasetconsisted
of 195 compounds from Vilar et al. [63], 119 compounds
from Platts et al. [64], 38 compounds from Naranayan and
Gunturi [43], 94 compounds from Mente and Lombardo
[33],147compoundsfromZhangetal.[40],197compounds
from Abraham et al. [65], 168 compounds from Garg and
Verma [66], 106 compounds from Guerra et al. [67], 95
compounds from Rose et al. [68], 36 compounds from
Kelder et al. [31], 165 compounds from Konovalov et al.
[69] and 36 compounds from Zerara et al. [70]. Many
compounds were reported multiple times with similar or
identical logBB values, especially drugs with CNS-related
effects such as antidepressants or neuroleptics. The average
of the logBB values was used for identical compounds
reported more than once. After removing duplicate struc-
tures, we ended up with 362 unique compounds with
experimental logBB values ranging from -2.2 to ?1.6. 199
logBB values were positive, 163 were negative or zero.
From this set we also wanted to exclude actively
transported compounds, since their mechanism of passing
the BBB is different to those passively entering CNS.
Therefore we searched for substrates of P-Gp, one of the
Fig. 2 Comparison of two
different strategies to calculate
the hydrophobic center
(red sphere) for compounds
with halogen atoms (like
perphenazine). On the left side,
the hydrophobic center is
calculated weighting atom
positions by their contribution
to logP prediction; on the
right side the calculation
is done with modiﬁcations
presented in this study
Fig. 3 Amitriptyline with hydrophilic center (yellow sphere), hydro-
phobic center (red sphere), amphiphilic axis (green line) and CSA
(green dotted area). This BBB-permeable compound illustrates the
role of the amphiphilic axis and the CSA
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viously published datasets [71–73]. Combining results
from these sources we excluded 18 known substrates of
P-Gp (bunitrolol, cimetidine, digoxin, domperidone, eto-
poside, fexofenadine, ﬂunitrazepam, levodopa, loperamide,
methotrexate, morphine, nevirapine, phenytoin, quinidine,
risperidone, triﬂupromazine, vincristine, yamatetan). In
addition to these 18 compounds, six compounds (chlor-
promazine, doxorubicin, nelﬁnavir, saquinavir, verapamil,
vinblastine) are reported ambiguously in the publications,
thus we did not exclude them.
To the best of our knowledge, this is to date the largest
set of quantitative logBB values, compiled from various
resources. This dataset promises to be a very elaborate and
reﬁned selection of compounds. The complete dataset can
be found in the supplementary material.
Descriptor calculation
We calculated all descriptors provided by MOE 2010.10
[59] and all from ACD/Labs (version 10.0) [74], that could
be calculated for all compounds. A complete list of
descriptors used is included the supplementary informa-
tion. In addition, we calculated descriptors reported to be
useful in other publications addressing BBB permeability,
as far as we were able to reproduce them. Table 1 lists all
additional descriptors together with a reference to their
original publication. We also implemented size intensive
descriptors using molecular weight as a normalizing factor
[75]. Finally, our data set comprised over 880 descriptors,
ranging from simple atom counts to computationally
intensive quantum–mechanical properties.
Quantitative models: beam search and multiple linear
regression
A large number of potentially predictive descriptors
prompted us to systematically reduce dimensionality (the
number of descriptors) used to construct and validate the
models. A beam search algorithm (width = number of
descriptors = 79) was applied to preselect potentially
predictive descriptors [78]. For each combination a boot-
strapped multiple linear regression was calculated and the
squared correlation coefﬁcient was returned as ﬁtness cri-
terion. We limited the maximum number of generations
and subsequently the number of descriptors simultaneously
taken into account to 10 and selected the best multiple
linear regression model per generation.
Qualitative models: beam search and random forest
To generate qualitative models our dataset was split into
BBB permeable (logBB C 0.3, n = 126) and non-
permeable (logBB B- 0.3, n = 76) compounds. The
compounds between the two limits (n = 142) were exclu-
ded from the process, as they do not show strong charac-
teristics of BBB permeable or non-permeable, respectively.
These limits were adapted from Abraham et al. [65], who
assume an experimental error of about 0.3 log units (logBB
values range from -2.2 to 1.6). We then performed a beam
search from 1 to 5 descriptors (width = number of
descriptors = 72). As qualitative model we constructed a
random forest model for each combination (ntree = 5,
depth = 5), validated by a bootstrapping procedure (sample
ratio = 1.0, number of validations = 100). Accuracy was
used as the main performance criteria. Again, we captured
the best models per generation.
All models were calculated using RapidMiner (version
5.1.1) and the Weka’s implementation of a random forest
algorithm. Correlation coefﬁcients were calculated
according to Pearson.
Results and discussion
We calculated the CSA for 32 compounds and compared it
with experimental values taken from Gerebztoff and Seelig
[56]. Similar to the original work we also achieved a good
correlation (r = 0.898) to experimental CSA values.
Quantitative models to predict logBB
The main intention of the present study was to investigate a
correlation between CSA and BBB permeability, as sug-
gested by Gerebtzoff and Seelig [56]. We therefore con-
structed multiple linear regression models using a beam
search algorithm for feature selection (up to 10 descriptors).
Table 2 shows the squared correlation to increase with
respect to the number of descriptors. Simultaneously, the
validated squared correlation is constant or even decreases
for more than 5 descriptors. Overall, statistical parameters
improve only slightly from 5 to 10 descriptors, although the
number of descriptors used is doubled. Thus inﬂuence of
additional descriptors must be questioned. The validated
squared correlation increases constantly up to 5 descriptors.
So we consider 5 as the maximum number of descriptors to
avoid overﬁtting.
In agreement with previous studies, TPSA is highly
important for BBB permeability. The number of polar
atoms (n_pol) and a descriptor taken from Feher et al. [30]
(I3), followed by the number of positive ionisable groups
(n_PI) and a descriptor developed for this study (PDist)
were also found to inﬂuence BBB permeability, as well as
the number of hydrogen bond acceptors (a_acc).
In contrast to our expectations, CSA never appeared in
the most predictive models. This leads to the question why
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TPSA, for example. For BBB-permeable compounds
Gerebtzoff and Seelig [56] suggest that there is an upper
limit for CSA at 80 A ˚ ´ 2. Figure 4a shows a scatterplot of
logBB versus calculated CSA values for our large dataset,
to further analyse this hypothesis. For 11 compounds, both
experimental and calculated values for CSA and logBB
were available. Overall, this plot does not show a clear
correlation between CSA and logBB. As suggested in the
original publication, we also investigated our dataset with
respect to logD (at pH 7.4) and CSA. In contrast to the
original publication Fig. 4b shows no signiﬁcant separation
by logD and CSA. A limit for BBB permeable compounds
reﬂected by the CSA could not be determined.
Correlation between CSA and number of atoms
Searching for structural and chemical information covered
by CSA, we tested its correlation with all other descriptors.
Overall, various descriptors correlate remarkably well with
the CSA. Table 3 lists the correlation with prominent other
descriptors, including those from the models listed in
Table 2. The majority of those are based on properties,
easily obtainable from the structure. Remarkably, CSA is
highly correlated to numerous simple descriptors that are
easier to calculate, such as the number of atoms (see
Fig. 5). A good correlation (r = 0.959) between those two
properties suggest that CSA can be seen as derivative of the
number of atoms. A high correlation of approximately 0.9
Table 1 List of molecular
descriptors developed or
reproduced in addition to the
standard descriptors by ACD/
Labs 10.0 and MOE 2010.10
Descriptor Description Reference
AA Length of the amphiphilic axis [56]
CSA Cross-sectional area perpendicular to the amphiphilic axis [56]
LAA Length along the amphiphilic axis
NOOM Number of atoms above the hydrophilic center
VOOM Volume above the hydrophilic center
li Longest distance from an ionized atom to another atom
mpc Longest distance from the atom with the highest partial charge
n_COOH Number of carboxylic acid functions [76]
n_hal Number of halogen atoms
n_ion Number of ionized atoms
QMAXneg Highest negative partial charge [76]
QMAXpos Highest positive partial charge [76]
QSUMH Sum of all partial charges on hydrogen atoms
QSUMO Sum of all partial charges on oxygen atoms [76]
QSUMN Sum of all partial charges on nitrogen atoms
n_OpN Sum of nitrogens and oxygen atoms [35]
N_XpC Sum of halogens and carbon atoms
LA Lipoafﬁnity [47]
logP-NO logP—number of oxygen and nitrogen atoms [35]
I3 ?1 for amines, -1 for acids, otherwise 0 [30]
n_PI Number of positive ionizable groups
QMAXneg Highest negative partial charge [76]
QMAXpos Highest positive partial charge [76]
QSUMH Sum of all partial charges on hydrogen atoms
QSUMO Sum of all partial charges on oxygen atoms [76]
QMINN Lowest partial charge on nitrogen atoms
QSUMN Sum of all partial charges on nitrogen atoms
QMEANN Average partial charge in nitrogen atoms
Qamines Average partial charge on amines
LA Lipoafﬁnity [47]
n_pol Number of polar atoms [77]
n_amines Number of amines
n_pN Number of protonated nitrogen atoms at pH 7
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reported previously that molecular weight contributes to
bioavailability in general [77]. Therefore we doubt that
CSA provides more information with respect to BBB
permeability than the number of atoms or molecular
weight.
Number of descriptors, dataset size and accuracy
Whenever we tried to construct multiple linear regression
models for logBB prediction on our large dataset, we failed
to achieve results comparable to those reported by others
using smaller data sets. To benchmark this relationship,
linear regression models were built based on a single
descriptor, but varying the composition of the training set.
As descriptor TPSA was chosen, since its impact on BBB
permeability has not only been demonstrated by the models
presented here but also by other researchers, for example
by Kelder et al. [31]. In their study a set of 45 compounds
was used to construct a regression model. Similarly, we
constructed subsets from our dataset consisting of 50–350
compounds and calculated the squared correlation coefﬁ-
cient for each model. Each subset size was tested 500 times
using different random seeds to cover different selection of
compounds. Figure 6 illustrates that small sets show a large
variability with respect to the squared correlation.
Although the number of possible subsets is much lower for
the large subsets, those are less likely to suffer from arbi-
trary correlations. This underlines the need for large data-
sets like the one we present here.
Table 2 Squared correlation coefﬁcients (raw and bootstrap validated) of the best models with 1–10 descriptors constructed with beam search
using multiple linear regression and squared correlation as performance criterion
natts Descriptor names r
2 rbootstrapping, 100
2
10 si_TotalFormalCharge, prot_n_pol, neutral_n_pol, a_don, PEOE_VSA_POL, PDist, I3, chi1,
logPow-logWeight, n_PI
0.585 0.508
9 si_TotalFormalCharge, prot_n_pol, neutral_n_pol, PEOE_VSA_PNEG, PDist, I3, apol,
logPow-logWeight, n_PI
0.577 0.534
8 si_TotalFormalCharge, prot_n_pol, neutral_n_pol, a_don, PDist, chi1, logPow-logWeight, n_PI 0.568 0.553
7 prot_n_pol, neutral_n_pol, a_don, PDist, chi1, logPow-logWeight, n_PI 0.558 0.537
6 prot_n_pol, neutral_n_pol, a_acc, PDist, prot_logPow-logWeight, neutral_n_PI 0.544 0.520
5 prot_n_pol, neutral_n_pol, a_acc, logPow-logWeight, n_PI 0.533 0.521
4 TPSA, I3, logPow-logWeight, n_PI 0.515 0.499
3 prot_n_pol, neutral_n_pol, logPow-logWeight 0.491 0.449
2 TPSA, logPow-logWeight 0.431 0.459
1 TPSA 0.354 0.221
Fig. 4 a Experimental logBB plotted against 11 experimental and
362 calculated CSA show no correlation. Blue dots represent
experimental CSA values, whereas grey dots are based on calculated
CSA values. b Colour coded scatterplot of CSA versus LogD (at
pH = 7.4), where green dots represent BBB permeable, red dots
represent non-BBB permeable and gray dots represent unclassiﬁed
compounds
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Focusing on a small number of descriptors, we were not
able to obtain simple models with high performance using
quantitative techniques. Thus we also calculated qualitative
models to predict BBB permeability using a random forest.
Again, we could compare our results to various published
studies [28, 38, 56].
For the qualitative models we used the same dataset as
for the quantitative models, but converted logBB values
into three bins. Compounds with a logBB C 0.3 comprise
the set of BBB permeable compounds, whereas compounds
with a logBB B 0.3 are considered as not BBB permeable.
The remaining compounds are excluded from the qualita-
tive modelling. This left us with a set of 202 compounds
for the training set. From the initial set of 886 descriptors,
only 72 descriptors remained after preselection. Similar to
the quantitative approach we aimed to obtain simple and
interpretable models with a maximum of 4 concurrent
descriptors. The beam search returned one model without
misclassiﬁcation (accuracy = 1.00) using four descriptors.
To evaluate the robustness of this model a bootstrap vali-
dation (n = 100) was applied. The complete results are
shown in Table 4.
The random forest prediction system based on four
descriptors also achieves a high validated accuracy. The
selected descriptors are similar to those obtained by mul-
tiple linear regressions and therefore highlight the impor-
tance of the following basic molecular properties:
• TPSA was selected in all models.
• QSUMN is the sum of charges on nitrogen atoms. This
classiﬁes all compounds by their charge on nitrogen
atoms and subsequently also discriminates compounds
having no nitrogen atom at all.
Table 3 Various commonly-known descriptors correlate well with
the CSA
Descriptor Correlation coefﬁcient
a_count 0.959
b_count 0.957
apol 0.955
a_heavy 0.929
Weight 0.897
WeinerPath 0.877
mpc 0.710
n_pol 0.645
TPSA 0.590
I3 0.317
n_PI 0.264
CSA may therefore be regarded as an expensive replacement for
much simpler descriptors. All descriptors are either standard MOE
descriptors or explained in Table 1
Fig. 5 CSA plotted against the number of atoms (a_count) reveals a
remarkably high correlation (r = 0.959)
Fig. 6 Different training sets with 50–350 examples all selected from
our dataset (n = 362) show that the size of the training set highly
inﬂuences the performance given by squared correlation, even when
constructed with exactly the same descriptor (TPSA) and the same
procedure
Table 4 Accuracies (raw and validated) of the best models and
prediction systems with up to 4 descriptors constructed using a beam
feature search in combination with random forest learners
natts Descriptor names Accuracytrees=5 Accuracybs,
n=100
4 TPSA, I3, QSUMN,
QSUMN/Weight
1.000 0.878
3 TPSA, QSUMN, QSUMN/
Weight
0.985 0.868
2 TPSA, QSUMN 0.970 0.864
1 TPSA 0.926 0.834
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calculated from QSUMN and the molecular weight. For
large compounds the molecular weight is the dominat-
ing factor for this descriptor.
• I3: Is -1 for acid compounds, ?1 for basic compounds
and 0 for the remaining compounds.
To analyse the dependence of the four descriptors we
also calculated the intercorrelation matrix (Table 5).
Although QSUMN and QSUMN/Weight are highly corre-
lated, both seem be predictive for logBB. Especially
compounds with higher molecular weight differ consider-
ably for the two descriptors.
Table 6 compares the results from our calculations with
results from other publications. The results clearly show
that random forest prediction systems are well-suited to
classify BBB permeability. Altogether, we outperformed
many other models trained on datasets with similar sizes in
terms of validated accuracy, even using fewer molecular
properties.
In contrast to results from quantitative models, qualita-
tive classiﬁcation models are able to predict BBB perme-
ability with high accuracy, especially when aiming for
simple models based on a small number of descriptors. To
quantify BBB permeability a more sophisticated and
complex model is needed. However, we have shown that
the number of descriptors that can be used is limited when
looking at validated performances. Using a high number of
descriptors for small datasets bears the risk of overﬁtting
and arbitrary correlations.
In contrast, we focused on a simple prediction system
that links BBB permeability to easily understandable
molecular properties. Focusing on a small number of
descriptors it might be easier to construct a binary classiﬁer
than to quantitatively predict BBB permeability.
Strengths and limitations
In the present study there are several novel ﬁndings:
• In addition to well-known descriptors, we added a
signiﬁcant number of descriptors that have never been
evaluated and validated in the context of BBB predic-
tion, for example size intensive descriptors (explained
in [75]), and other novel descriptors listed in Table 1.
Furthermore, we addressed the CSA which has been
proposed as being predictive for BBB permeability.
The qualitative models as shown in Table 4 include, in
addition to TPSA, two of these novel descriptors.
• All prediction systems are limited by the experimental
error of the data they are based on. Therefore, our set
consists of compounds with experimental logBB values
only, compiled from various publications.
• We developed an unparalleled compact and highly-
predictive qualitative model validated by bootstrapping,
that might act as general guideline for estimating BBB
permeability.
Conclusion
In this work, we applied qualitative and quantitative in
silico techniques to predict BBB permeability. For this
purpose we created a reasonably large dataset (n = 362) of
experimental logBB values. For each compound of the
training set we calculated a broad set of descriptors ranging
from simple atom count descriptors to computational more
expensive descriptors like the CSA perdendicular to the
amphiphilic axis. For this special descriptor were also able
to validate calculated CSA with a set of experimentally
measured values (n = 32).
The best quantitative prediction system based on mul-
tiple linear regression without overﬁtting yielded a boot-
strapped squared correlation coefﬁcient of 0.521.
Qualitative models based on a random forest performed
remarkably better. The best prediction system based on
only four descriptors achieved a bootstrap validated accu-
racy of 88% (unvalidated 100%). Remarkably, the CSA
was not chosen by the feature selection algorithm used to
select the most predictive descriptors. In contrast, a
Table 5 Intercorrelation matrix for the four descriptors used in the
best random forest prediction model
TPSA I3 QSUMN QSUMN/Weight
TPSA 1.000
I3 0.054 1.000
QSUMN -0.617 -0.492 1.000
QSUMN/Weight -0.374 -0.536 0.790 1.000
Table 6 Results of
classiﬁcation systems for BBB
permeability taken from the
literature
SVM support vector machine,
DT decision tree, RF random
forest, CV cross-validation, BS
bootstrapping
Method Validation Number of descriptors Dataset size Overall accuracy Reference
SVM 10-fold CV \100 351 83.0 [28]
DT – 2 43 86.0 [56]
SVM 10-fold CV 8 351 80.0 [28]
SVM 5-fold CV 5 415 79.1 [38]
RF 100 BS 4 202 88.2 This work
J Comput Aided Mol Des (2011) 25:1095–1106 1103
123combination of simple and well-known descriptors was
found to be most useful to predict logBB.
Finally, we also showed that large and carefully com-
prised datasets, like the one presented here, reduce the risk
of arbitrary correlations and result in more reproducible
and robust models.
Support information
The SVL script to calculate and visualize the CSA per-
pendicular to the amphiphilic axis is provided as well as a
spreadsheet ﬁle containing the whole set of compounds
together with their corresponding logBB as well as a
complete list of the descriptors calculated by ACD/Labs
10.0 and MOE 2010.10 for free download.
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